Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Assessing Changes In Berkshire Hathaway Holdings

2018-02-23 seekingalpha
Some major changes in holdings occurred at Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) in its investment portfolio over the latest quarter. Today we will expose the changes and rate those purchases and sales with our Friedrich algorithm. (407-6)

United Therapeutics (UTHR) Q4 Earnings Decline on High Costs

2018-02-22 zacks
United Therapeutics Corporation (UTHR - Free Report) reported adjusted earnings of $3.89 per share in the fourth quarter of 2017, which declined 4.2% from the year-ago quarter due to higher operating costs. The Zacks Consensus Estimate was pegged at $1.94 per share. (135-0)

Middlemen Play Gatekeeper in Battle to Curb Soaring Drug Costs - Bloomberg

2018-02-22 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (347-1)

Teva's Problems Continue to Mount With No Relief in Sight

2018-02-21 zacks
Israel-based drugmaker, Teva Pharmaceutical Industries Limited (TEVA - Free Report) is in a major mess right now. The question now is how will the world’s largest generic maker recover? (266-1)

Invest Like Warren Buffett With These ETFs

2018-02-20 zacks
Following investing strategies of billionaire investor Warren Buffett is everyone’s dream. Buffett’s Berkshire Hathaway Inc. (BRK.B - Free Report) has added more than 100% over the last five years (as of February 15, 2018), way better than the 73% gain of the broader market ETF SPDR S&P 500 ETF (SPY - Free Report) during the same time frame. (165-1)

How Amazon Could Lose Its Healthcare Bid While Drug Distributor Stocks Win

2018-02-19 seekingalpha
Amazon.com (NASDAQ:AMZN) has been one of the most innovative and disruptive companies of this century, with incredible success in areas that lie outside of what has been historically perceived as its core business (book selling). (557-3)

Valeant: Generic Syprine Is Finally Here

2018-02-19 seekingalpha
Hits to Syprine and Cuprimine could hurt sentiment for VRX. LOE for Apriso and Uceris tablets could be on the horizon. (129-0)

You May Not Want To Follow Buffett Out Of Phillips 66

2018-02-18 seekingalpha
Berkshire Hathaway announced that they had reached an agreement with Phillips 66 wherein the business would buy back $3.3 billion of its own stock from Berkshire. (329-1)

It’s Time to Add Teva Pharmaceutical Industries Ltd (ADR) Stock to Your Watchlist

2018-02-16 investorplace
Just one day after Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) issued some lackluster guidance followed by news that a competing drug had won the FDA’s approval, TEVA stock got an impressive endorsement. Warren Buffett’s Berkshire Hathaway bought $358 million worth of the beaten-down equity during the fourth quarter of last year. (174-0)

Even Warren Buffett's Magic Can't Help Kraft Heinz - Bloomberg

2018-02-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (167-0)

Backstory: Warren Buffett's Valentine's Day surprise for investors

2018-02-16 in.reuters
NEW YORK (Reuters) - Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical Industries Ltd.    (331-2)

Warren Buffett's Valentine's Day surprise for investors - Channel NewsAsia

2018-02-16 channelnewsasia
NEW YORK: Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical Industries Ltd .    (331-0)

Warren Buffett's Valentine's Day surprise for investors

2018-02-16 reuters
NEW YORK (Reuters) - Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical Industries Ltd (TEVA.TA).    (331-0)

Berkshire Buys Teva: Analysis, And Why It Matters To All Investors

2018-02-15 seekingalpha
This article provides reasons I am investing elsewhere in the biotech/pharma space and find no fundamental price at which TEVA would be clearly undervalued. (163-4)

Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva

2018-02-15 cnbc
After news hit yesterday that Warren Buffett's Berkshire Hathaway had made a $358 million investment investment in Israel-based drug company Teva Pharmaceutical Industries, a skepticism lingered even as shares of the heavily shorted stock soared. (167-2)


CUSIP: M8769Q136